-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

632.P1.74 632. Chronic Myeloid Leukemia: Therapy: Poster I

Program: Oral and Poster Abstracts
Type: Poster
Saturday, December 1, 2018: 6:15 PM-8:15 PM
Hall GH (San Diego Convention Center)

Chung Hoow Kok, PhD, BSc1,2, Sakrapee Paisitkriangkrai, PhD3*, David T Yeung, PhD, BSc, FRACP, FRCPA, MBBS2,4,5,6, Liu Liu, PhD, BSc2,4*, Verity A Saunders4*, Phuong Dang4*, Agnes S. M. Yong, MD, PhD2,4,5, Deborah L White, PhD2,4,6,7 and Timothy P. Hughes, MD, MBBS, FRACP, FRCPA2,4,5,6

1Cancer Theme, South Australian Health and Medical Research Institute, North Adelaide, SA, Australia
2Adelaide Medical School, The University of Adelaide, Adelaide, Australia
3School of Computer Science, The University of Adelaide, Adelaide, Australia
4Cancer Theme, South Australian Health and Medical Research Institute, Adelaide, Australia
5Department of Haematology, Royal Adelaide Hospital and SA Pathology, Adelaide, Australia
6Australasian Leukaemia and Lymphoma Group, Melbourne, Australia
7School of Biological Sciences. Faculty of Sciences, University of Adelaide, Adelaide, Australia

Jorge E. Cortes, MD1, Carlo Gambacorti-Passerini, MD2, Michael W. Deininger, MD, PhD3, Elisabetta Abruzzese4, Liza DeAnnuntis5* and Tim H Brümmendorf, MD6

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2School of Medicine and Surgery, University of Milano Bicocca, Monza, MB, Italy
3Division of Hematology and Hematologic Malignancies, University of Utah, Salt Lake City, UT
4Hematology, S.Eugenio Hospital, Roma, Italy
5Pfizer Inc, Collegeville, PA
6Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Universitätsklinikum RWTH, Aachen, Germany

Jorge E. Cortes, MD1, Clara Chen, PhD, BS, MS2*, Michael J. Mauro, MD3, Ginny P Sen, MPH4*, Srikanth Gajavelli, MD2*, Catherine Davis, PharmD5* and Stuart L. Goldberg, MD6

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Bristol-Myers Squibb, Princeton, NJ
3Myeloproliferative Neoplasms Program, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY
4ICON Clinical Research LLC, South San Francisco, CA
5Bristol-Myers Squibb Co., Princeton, NJ
6Hackensack University Medical Center, Hackensack, NJ

Naranie Shanmuganathan, MBBS1,2,3,4,5,6, Susan Branford, PhD3,5,6,7,8, Agnes S. M. Yong, MD, PhD2,3,9, Devendra K Hiwase, MBBS, MD, FRACP, FRCPA, PhD2,3,10, David T Yeung, PhD, BSc, FRACP, FRCPA, MBBS2,3,6,11,12, David M Ross2,3,11,13,14* and Timothy P. Hughes, MD2,3,6,11

1Department of Haematology, Royal Adelaide Hospital and SA Pathology, Brompton, SA, Australia
2Cancer Theme, South Australian Health and Medical Research Institute, Adelaide, Australia
3School of Medicine, University of Adelaide, Adelaide, Australia
4Haematology Society of Australia & New Zealand, Sydney, Australia
5Centre for Cancer Biology, SA Pathology, Adelaide, Australia
6School of Pharmacy and Medical Science, University of South Australia, Adelaide, Australia
7Department of Genetics and Molecular Pathology, SA Pathology, Adelaide, Australia
8School of Biological Sciences, SA Pathology, Adelaide, SA, Australia
9Adelaide Cancer Centre, Adelaide, Australia
10Department of Haematology, Royal Adelaide Hospital and SA Pathology, Adelaide, SA, Australia
11Department of Haematology, Royal Adelaide Hospital and SA Pathology, Adelaide, Australia
12Australasian Leukaemia and Lymphoma Group, Melbourne, Australia
13School of Medicine, Flinders University, Adelaide, Australia
14Department of Haematology, Flinders Medical Centre, Bedford Park, Australia

Gianni Binotto1*, Fausto Castagnetti2, Gabriele Gugliotta, MD, PhD2, Elisabetta Abruzzese3, Massimo Breccia, MD4*, Alessandra Iurlo5*, Fabio Stagno, MD, PhD6, Antonella Gozzini7*, Patrizia Pregno8*, Sara Galimberti9*, Carmen Fava10, Alessandro Isidori11, Gaetano La Barba12*, Mario Tiribelli13*, Massimiliano Bonifacio14*, Mario Annunziata15*, Luigiana Luciano16, Isabella Capodanno17*, Monica Bocchia, MD, PhD18*, Francesca Lunghi19*, Luciano Levato20*, Luca Frison21*, Monika Trawinska Malgorzata3*, Fabrizio Pane16, Giuseppe Saglio10, Michele Baccarani, MD2, Gianpietro Semenzato21* and Gianantonio Rosti2*

1Dept. of Medicine, Hematology and Clinical Immunology, Padua School of Medicine, PADOVA, Italy
2Institute of Hematology "L. and A. Seràgnoli", Department of Experimental, Diagnostic and Specialty Medicine, Bologna, Italy
3Hematology, S.Eugenio Hospital, Roma, Italy
4Division of Cellular Biotechnologies and Hematology, University "Sapienza", Roma, Italy
5Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy
6Hematology Unit, Hematology Section, Biomedical Sciences, Trecastagni, Catania, Italy
7Divisione di Ematologia-Policlinico Careggi di Firenze, Firenze, ITA
8Hematology Unit, Az Ospedaliero Universitaria Città' della Salute e della Scienza, Torino, Italy
9Section of Hematology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy
10Hematology Division, Ospedale Mauriziano, University of Turin, Torino, Italy
11Hematology and Stem Cell Transplant Center, AORMN Hospital, Pesaro, Italy
12Department of Hematology, "Spirito Santo" Hospital, Pescara, ITA
13Division of Hematology and BMT, Department of Medical Area, University of Udine, Udine, Italy
14Department of Medicine, Section of Haematology, University of Verona, Verona, Italy
15Hematology, Ospedale Cardarelli, Napoli, Italy
16Hematology Unit, Federico II University of Naples, Napoli, Italy
17Hematology Department, Arcispedale Santa Maria Nuova - IRCCS Reggio, Reggio Emilia, Italy
18Chair of Hematology, University of Siena, Azienda Ospedaliera Universitaria, Siena, Italy
19Haematology and Bone Marrow Transplant Unit, San Raffaele Scientific Institute IRCCS, Milano, Italy
20Department Hematology-Oncology, Azienda Ospedaliera Pugliese-Ciaccio, Catanzaro, Italy
21Dept. of Medicine, Hematology and Clinical Immunology, Padua School of Medicine, Padova, Italy

Young Rok Do, PhD, MD1, Jae-Yong Kwak, MD, PhD2, Hawk Kim, MD, PhD3, Jeong-A Kim, MD, PhD4, Hyeoung-Joon Kim, MD, PhD5, Joon Seong Park, MD6*, Jooseop Chung, Doctor7, Ho-Jin Shin, MD, PhD8*, Sung-Hyun Kim, MD, PhD9, Udomsak Bunworasate, MD10*, Chul Won Choi, MD, PhD11*, Narcisa Sonia Cornejo Comia, MD12*, Dae Young Zang, MD, PhD13*, Sukjoong Oh, MD, PhD14, Saengsuree Jootar, MD15*, Ary Harryanto Reksodiputro, MD, PhD16*, Won-Sik Lee, MD17, Yeung-Chul Mun, MD, PhD18*, Jee Hyun Kong, MD19*, Priscilla B. Caguioa, MD20*, Jinny Park, MD, PhD21, Chul W. Jung, MD, PhD22 and Dong-Wook Kim, MD, PhD23

1Department of Internal Medicine, Dongsan Medical Center Keimyung University, Daegu, Korea, Republic of (South)
2Department of Internal Medicine, Chonbuk National University Medical School, Jeonju, Korea, Republic of (South)
3Division of Hematology, Ulsan University Hospital, College of Medicine, Incheon, South Korea
4Department of Hematology, The Catholic University of Korea, St. Vincent’s Hospital, Suwon, Korea, Republic of (South)
5Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Hwasun, Korea, Republic of (South)
6Ajou University School of Medicine, Suwon, Korea, Republic of (South)
7Department of Hematology-oncology, Pusan National University Hospital, Busan, Korea, Republic of (South)
8Department of Internal Medicine, Pusan National University Hospital, Busan, Korea, Republic of (South)
9Dong-A University Hospital, Busan, Korea, Republic of (South)
10Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand
11Divison of Hematology-Oncology, Department of Internal Medicine, Korea University College of Medicine, Guro Hospital, Seoul, Korea, Republic of (South)
12Mary Mediatrix Med. Ctr., Lipa City, PHL
13Department of Internal Medicine, Hallym University College of Medicine, Hallym University Hospital, Anyang, Korea, Republic of (South)
14Division of Hematology-Oncology, School of Medicine, Sungkyunkwan University, Kangbuk Samsung Hospital, Seoul, Korea, Republic of (South)
15Division of Hematology, Department of Internal Medicine, Ramathibodi Hospital, Bangkok, Thailand
16Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia
17Inje Univ. Busan Baik-Hospital, Busan, Korea, Republic of (South)
18Ewha Womans University Mokdong Hospital, Seoul, Korea, Republic of (South)
19Division of Hematology-oncology, Department of Internal Medicine, Wonju Severance Christian Hospital, Yonsei University College of Medicine, Wonju, Korea, Republic of (South)
20St. Luke's Medical Center Cancer Institute, Quezon City, PHL
21Division of Hematology, Gachon University Gil Medical Center, Incheon, Korea, Republic of (South)
22Samsung Medical Center, Seoul, KOR
23Department of Hematology, Seoul St. Mary's Hospital The Catholic University of Korea, Seoul, South Korea

Michael W. Deininger, MD, PhD1, Vamsi Kota, MBBS2, Jeff H. Lipton, MD, PhD3, Dragana Milojkovic, MBBS, PhD4*, Valentín García Gutiérrez, PhD5, Eric Leip, PhD6*, Sonja Nick, MSc7*, Andreas Hochhaus, MD8, Carlo Gambacorti-Passerini, MD9, Jorge E. Cortes, MD10 and Tim H. Brummendorf, MD11

1Division of Hematology and Hematologic Malignancies, University of Utah, Salt Lake City, UT
2Department of Hematology and Oncology, Winship Cancer Instiute of Emory University, Atlanta, GA
3Blood and Marrow Transplant Program, Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
4Department of Haematology, Hammersmith Hospital (Imperial College Healthcare NHS Trust), London, United Kingdom
5Hematology Department, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain
6Pfizer Inc, Cambridge, MA
7Pfizer AG, Zurich, Switzerland
8Klinik für Innere Medizin II, Abt. Hämatologie und Internistische Onkologie, Universitätsklinikum Jena, Jena, Germany
9School of Medicine and Surgery, University of Milano Bicocca, Monza, MB, Italy
10Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
11Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty, Universitätsklinikum RWTH Aachen, Aachen, Germany

Sergei M. Kulikov, PhD1*, Anna G Turkina, Prof., MD2, Anton Kulikovsky3*, Olga Lazareva, PhD4*, Sergey Kutsev, Prof., MD., PhD5,6*, Elza Lomaia, MD7*, Andrey Zaritskey, MD, PhD8*, Anatoly Golenkov, MD, Prof9*, Tatiana Pospelova, MD, PhD10*, Satokhin Yuri, MD, PhD11*, Tatiana Konstantinova, MD, PhD12*, Elena N. Parovichnikova, MD, PhD2* and Valeriy G. Savchenko, MD, PhD2

1Department of information and analysis, National Research Center for Hematology, NovyZykovski pr. 4, Russian Federation
2National Research Center for Hematology, Moscow, Russian Federation
3Department of information and analysis, National Research Center for Hematology, Moscow, Russian Federation
4Department of Chemotherapy of myeloprolypherative disorders, National Research Center for Hematology, Moscow, Russia
5Research Centre of Medical Genetics, Moscow, RUS
6Russian National Medical Research University - NI Pirogov, Moscow, RUS
7Almazov Medical Research Centre, Saint Petersburg, Russia
8Centre for Heart, Blood & Endocrinology named after V.A.Almazov, St-Petersburg, Russia
9Department of Hematology, Moscow Regional Research and Clinical Institute, Moscow, Russian Federation
10Novosibirsk State Medical University, Novosibirsk, Russian Federation
11State Medical University of Rostov, Rostov, Russian Federation
12Regional Clinical Hospital №1, Ekaterinburg, Russian Federation

Christel C. Boons, MSc*, Yvonne den Hartog*, Jeroen J. Janssen, MD, PhD, Anthe S. Zandvliet, PharmD, PhD*, René Vos*, Eleonora L. Swart, PharmD, PhD*, N. Harry Hendrikse, PharmD, PhD* and Jacqueline G. Hugtenburg, PharmD, PhD*

Amsterdam UMC, Amsterdam, Netherlands

Qian Wang, MD, MPH1, Yaning Zhang, MD2*, Bing Yue, MD1*, Yu Zhang, MD3*, Changchuan Jiang, MD MPH1*, Stuthi Perimbeti, MD, MPH1* and Michael J. Mauro, MD4

1Department of Medicine, Icahn School of Medicine at Mount Sinai St. Luke's and West, New York, NY
2Department of General Surgery, Cleveland Clinic, Cleveland, OH
3Department of Hematology, 307 Hospital of People's Liberation Army (PLA) of China, Beijing, China
4Myeloproliferative Neoplasms Program, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY

Mary Alikian1,2*, Rebecca Ellwood1*, Olga Tatarinova1*, Graham David Rose3*, George Nteliopoulos1*, Gareth Gerrard4*, Jamshid S Khorashad, MD, PhD1,5*, Dragana Milojkovic, MBBS, PhD6*, Alistair Reid, BSc, PhD7*, Letizia Foroni, MD, PhD1*, Richard Clark, MBBS, MRCP, MRCPath, MD8* and Jane Apperley, MB ChB MD1

1Centre for Haematology, Imperial College London at Hammersmith Hospital, London, United Kingdom
2Molecular Pathology, Imperial Colelge Healthcare NHS Trust, London, United Kingdom
3Molecular Pahology, Imperial college Healthcare NHS Trust, london, United Kingdom
4UCL Cancer Institute, University College London, London, United Kingdom
5Molecular Pathology, Imperial College Healthcare NHS Trust, london, United Kingdom
6Department of Haematology, Imperial College London at Hammersmith Hospital, London, United Kingdom
7Molecular Pathology Unit, Royal Liverpool University Hospital, Liverpool University, Liverpool, United Kingdom
8Royal Liverpool University Hospitals NHS Trust, Liverpool, GBR

Afaf Osman, MD1, Brian Yu1*, Nancy Glavin1*, Tamar S. Polonsky1*, James K. Liao1* and Richard A. Larson, MD2

1Department of Medicine, University of Chicago, Chicago, IL
2Department of Medicine and Comprehensive Cancer Center, University of Chicago, Chicago, IL

Oleg Shukhov, MD, PhD1*, Ekaterina Chelysheva, MD, PhD2*, Anna Petrova, MD1*, Anastasiya Bykova, MD3*, Irina Nemchenko, MD, PhD3*, Galina Gusarova, MD, PhD3*, Eduard Gemdzhian3* and Anna G Turkina, Prof., MD3

1National Research Center for Hematology, Moscow, Russia
2National Research Center for Hematology, Moscow, AZ
3National Research Center for Hematology, Moscow, Russian Federation

Matteo Molica, MD1*, Emilia Scalzulli, MD2*, Alunni Fegatelli Danilo3*, Roberto Latagliata2*, Gioia Colafigli, MD2*, Lorenzo Rizzo4*, Daniela Diverio2*, Robin Foà, MD2 and Massimo Breccia, MD5*

1Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy
2Department of Cellular Biotechnologies and Hematology, University "Sapienza", Rome, Italy
3Department of Statistical Sciences, Sapienza University, Rome, Italy
4Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University of Rome, Policlinico Umberto I, Rome, Italy
5Division of Cellular Biotechnologies and Hematology, University "Sapienza", Roma, Italy

Bogdan Muresan, MSc1*, Carla M. Mamolo, PhD2*, Joseph C Cappelleri, PhD, MPH, MS2*, Rocco J. Crescenzo, MD3, Eric Leip, PhD4*, Andrea Viqueira, MD5* and Bart Heeg, PhD1*

1Ingress Health, Rotterdam, Netherlands
2Pfizer Inc, Groton, CT
3Pfizer Inc, Walton Oaks, United Kingdom
4Pfizer Inc, Cambridge, MA
5Pfizer SLU, Madrid, Spain

Vaclava Polivkova1*, Nikola Curik1*, Hana Zizkova1*, Adela Benesova1*, Pavel Burda1*, Pavla Pecherkova1*, Eliska Motlova1*, Jana Brezinova1*, Sarka Ransdorfova1*, Hana Klamova1*, Lenka Hovorkova2*, Jan Zuna2, Thomas Ernst3, Simona Soverini, PhD4 and Katerina Machova5*

1Institute of Hematology and Blood Transfusion, Prague, Czech Republic
2CLIP, Dept. of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic
3Abteilung Hämatologie/Onkologie, Klinik für Innere Medizin II, University of Jena, Jena, Germany
4Institute of Hematology "L. and A. Seràgnoli", Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, "S. Orsola-Malpighi" Hospital, Castel Maggiore, Bologna, Italy
5Institute of Hematology and Blood Transfusion, PRAGUE, Czech Republic

Timothy Devos1, Koen Theunissen2*, Fleur Samantha Benghiat3*, Alain Gadisseur4, Stef Meers5, Dominik Selleslag6, Gaëtan Vanstraelen7*, Pierre Zachée8*, Marc André9*, Philippe Lewalle, MD10*, Mia Janssen11*, Rik Schots12*, Koen Van Eygen13*, Alain Kentos14*, Marie Lejeune15*, Agnes Triffet16*, Inge Vrelust17*, Carolina Kuipers18* and Violaine Havelange19*

1Department of Hematology, University Hospitals Leuven (UZ Leuven), Leuven, Belgium
2Jessa Ziekenhuis, Hasselt, BEL
3Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium
4Hematology, University Hospital Antwerp, Edegem, Belgium
5Algemeen Ziekenhuis Klina, Brasschaat, BEL
6Algemeen Ziekenhuis Sint-Jan Brugge, Brugge, BEL
7CHR Verviers, Verviers, BEL
8Ziekenhuis Netwerk Antwerpen Stuivenberg, Antwerpen, Belgium
9Department of Hematology, CHU UCL Namur, Site Godinne, Yvoir, Belgium
10Institut Jules Bordet, Brussels, Belgium
11Ziekenhuis Oost-Limburg, Genk, Belgium
12UZ-Brussel-VUB, Jette, Belgium
13Algemeen Ziekenhuis Groeninge, Kortrijk, Belgium
14Hôpital de Jolimont, Haine-Saint-Paul, Belgium
15Centre Hospitalier Universitaire de Liège (Sart-Tilman) and Centre Hospitalier Universitaire Brugmann, Liege, Brussels, BEL
16Centre Hospitalier Universitaire Charleroi Vésale, Charleroi, BEL
17Algemeen Ziekenhuis Sint-Elisabeth, Turnhout, Belgium
18Incyte Biosciences Benelux, Amsterdam, NLD
19Section of Hematology, Cliniques Universitaires Saint-Luc, Brussels, Belgium

Jee Hyun Kong, MD1*, Tae-Hwa Go2*, Jung Yeon Lee, M.D.1*, Hye Bin Song1*, Hohyung Nam1*, Jieun Uhm, MD, PhD3 and Shin Young Hyun, MD1*

1Division of Hematology-oncology, Department of Internal Medicine, Wonju Severance Christian Hospital, Yonsei University College of Medicine, Wonju, Korea, Republic of (South)
2Center of Biomedical Data Science, Wonju Severance Christian Hospital, Yonsei University College of Medicine, Wonju, Korea, Republic of (South)
3Division of Hematology and Oncology, Department of Internal Medicine, Hanyang University Seoul Hospital, Hanyang University College of Medicine, Seoul, Korea, Republic of (South)

Daniela De Benedittis, MD1*, Massimo Breccia, MD2*, Ida Carmosino1*, Elena Mariggiò, MD1*, Matteo Molica, MD3*, Sara Mohamed, MD1*, Fulvio Massaro, MD4*, Maria Lucia De Luca, MD1*, Emilia Scalzulli, MD1*, Chiara Lisi, MD1*, Mauro Passucci, MD1*, Gioia Colafigli, MD1*, Maria Giovanna Loglisci, MD1*, Daniela Diverio1*, Marco Mancini5*, Robin Foà, MD1 and Roberto Latagliata1*

1Department of Cellular Biotechnologies and Hematology, University "Sapienza", Rome, Italy
2Division of Cellular Biotechnologies and Hematology, University "Sapienza", Roma, Italy
3Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy
4Department of Biotechnologies and Hematology, University "Sapienza", Rome, Italy
5Department of Cellular Biotechnologies and Hematology, University "Sapienza", Roma, Italy

Ravichandran Ambalathandi, MBBS, MD1*, Rajani Priya Yedla, MD, MBBS2*, Nageswara Reddy Palukuri, MBBS, DNB, SR Medical Oncology3*, Stalin Chowdary Bala, MBBS, MD, DM, DNB2,4*, Meher Lakshmi Konatam, MBBS, MD, DM2*, Sadashivudu Gundeti, DM, MBBS, MD5 and Venkateswar Rao Pydi, MBBS, MD6

1MEDICAL ONCOLOGY, NIZAM'S INSTITUTE OF MEDICAL SCIENCES, MEDICAL ONCOLOGY, IND, HYDERABAD, TELANGANA, India
2Medical Oncology, NIzam's Institute of Medical Sciences, Hyderabad, India
3Medical Oncology, Nizam's Institute of Medical Sciences, Hyderabad, India
4MEDICAL ONCOLGY, NIZAM'S INSTITUTE OF MEDICAL SCIENCES, HYDERABAD, India
5Medical Oncology, NIzam's Institute of Medical Sciences, Hyderabad, IND
6Nizams Institute of Medical Sciences, Hyderabad, IND

Adalet Meral Gunes1*, Frédéric Millot, MD2*, Krzysztof Kalwak, MD3*, Birgitte Lausen, MD, PhD4, Petr Sedlacek, MD5*, Birgitte Versluijs6*, Michael Dworzak, MD7*, Barbara De Moerloose, MD, PhD8,9* and Meinolf Suttorp, PhD, MD10

1Pediatric Hematology and Oncology, Uludag Unıv., Bursa, Turkey
2Department of Pediatric Hematology-Oncology, CHU Poitiers, Poitiers, France
3Dept. Pediatric Hematology/Oncology and BMT, Cape of Hope Wroclaw Medical University, Wroclaw, Poland
4Dept of Pediatrics and Adolescent Medicine, University Hospital Rigshospitalet, Copenhagen, Denmark
5Department of Pediatric Hematology–Oncology, University Hospital Motol, Charles University, Prague, Czech Republic
6Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands
7Department of Pediatrics, St. Anna Children's Hospital and Children’s Cancer Research Institute, Vienna, Austria
8Department of Pediatric Hematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, Ghent, Belgium
9Department of Paediatric Haematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, Gent, Belgium
10Department of Pediatric Hematology and Oncology, Universitaetsklinikum "carl Gustav Carus" Klinik Und Poliklinik Fuer Kinderheilk, Dresden, Germany

Matheus Sebastian Da Silva1*, Eliana C Miranda1*, Marcia Torresan Delamain, MD2*, Gislaine Oliveira Duarte, MD1*, Bruna R Vergilio1*, Ana Beatriz Pascoal Lopes1*, Jessica CN Vianna1*, Carmino Antonio De Souza, MD, PhD1*, Erich Vinicius De Paula, MD, PhD3 and Katia B Pagnano, MD4

1Centro de Hematologia e Hemoterapia, University of Campinas, Campinas, Brazil
2Centro de Hematologia e Hemoterapia, State University of Campinas, Campinas, Brazil
3Centro de Hematologia e Hemoterapia, University of Campinas, Campinas, SP, Brazil
4INCT do Sangue Hemocentro UNICAMP, University of Campinas, Campinas, SP, Brazil

Fabrizio Pane1, Luigia Luciano, MD2, Novella Pugliese, MD3*, Juan Luis Steegman, Prof4*, Peter E. Westerweel, MD5*, Elisabetta Abruzzese, MD6, Massimo Breccia, MD7*, Monica Bocchia, MD, PhD8*, Simona Soverini, PhD9, Fausto Castagnetti, MD, PhD10, Maria Monteverde11*, Gianantonio Rosti12*, Giuseppe Saglio13 and Jeroen J. Janssen, MD, PhD14

1Hematology Unit, Federico II University of Naples, Napoli, Italy
2Hematology Unit, Federico II University of Naples, Napoli, ITA
3Hematology Unit, University Federico II, Naples, Italy
4Hospital La Princesa, Madrid, Spain
5Internal Medicine, Albert Schweitzer Hospital, Dordrecht, Netherlands
6Haematology Unit, S. Eugenio Hospital, Rome, Italy
7Division of Cellular Biotechnologies and Hematology, University "Sapienza", Roma, Italy
8Chair of Hematology, University of Siena, Azienda Ospedaliera Universitaria, Siena, Italy
9Institute of Hematology "L. and A. Seràgnoli", Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, "S. Orsola-Malpighi" Hospital, Castel Maggiore, Bologna, Italy
10Institute of Hematology "L. e A. Seràgnoli", DIMES, University of Bologna, Bologna, Italy
11University of Naples Federico II, Naples, Italy, Napoli, Italy
12Department of Experimental, Diagnostic and Specialty Medicine - DIMES, Institute of Hematology "L. and A. Seràgnoli", S.Orsola-Malpighi University Hospital, Bologna, Italy
13Hematology Division, Ospedale Mauriziano, University of Turin, Torino, Italy
14Amsterdam UMC, Amsterdam, Netherlands

Naoto Takahashi, MD1, Masahiro Kizaki, MD, PhD2, Masatomo Miura, PhD3*, Tatsuya Kawaguchi, MD, PhD4, Ritsuro Suzuki, MD, PhD5, Kazuhito Yamamoto, MD, PhD6, Kazunori Ohnishi, MD, PhD7, Itaru Matsumura, MD8, Tomoki Naoe, MD, PhD9 and Koichi Akashi, MD, PhD10

1Department of Hematology, Nephrology and Rheumatology, Akita University Graduate School of Medicine, Akita, Japan
2Department of Hematology, Saitama Medical Center, Saitama Medical University, Saitama, Japan
3Department of Pharmacy, Akita University Hospital, Akita, Japan
4Department of Medical Technology, Kumamoto Health Science University, Kumamoto, Japan
5Department of Oncology and Hematology, Shimane University Hospital, Izumo, Japan
6Department of Hematology and Cell Therapy, Aichi Cancer Center, Nagoya, Japan
7Japanese Red Cross Aichi Blood Center, Seto, Japan
8Kindai University Faculty of Medicine, Osaka-Sayama, Japan
9National Hospital Organization Nagoya Medical Center, Nagoya, Japan
10Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan

*signifies non-member of ASH